Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.4398
0.02014.79%
At close: May 15, 5:00 PM EST
$0.4311
-0.0087-1.98%
After Hours: May 15, 4:27 PM EST
CollPlant Biotechnologies Ltd Analyst Ratings
CLGNNASDAQ
CollPlant Biotechnologies Analyst Ratings and Price Targets | NASDAQ:CLGN | Benzinga
CollPlant Biotechnologies Ltd has a consensus price target of $12.5 based on the ratings of 3 analysts. The high is $14 issued by EF Hutton on August 20, 2024. The low is $11 issued by HC Wainwright & Co. on August 21, 2025. The 3 most-recent analyst ratings were released by D. Boral Capital on November 28, 2025, October 20, 2025, and September 16, 2025, respectively. With an average price target of $12 between D. Boral Capital, there's an implied 2683.58% upside for CollPlant Biotechnologies Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
EF Hutton
1calculated from analyst ratings
Analyst Ratings for CollPlant Biotechnologies
Loading calendar...
FAQ
What is the target price for CollPlant Biotechnologies (CLGN) stock?
The latest price target for CollPlant Biotechnologies (NASDAQ:CLGN) was reported by D. Boral Capital on February 6, 2026. The analyst firm set a price target for $0.00 expecting CLGN to fall to within 12 months (a possible -100.00% downside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CollPlant Biotechnologies (CLGN)?
The latest analyst rating for CollPlant Biotechnologies (NASDAQ:CLGN) was provided by D. Boral Capital, and CollPlant Biotechnologies downgraded their hold rating.
When was the last upgrade for CollPlant Biotechnologies (CLGN)?
There is no last upgrade for CollPlant Biotechnologies
When was the last downgrade for CollPlant Biotechnologies (CLGN)?
The last downgrade for CollPlant Biotechnologies Ltd happened on February 6, 2026 when D. Boral Capital changed their price target from N/A to N/A for CollPlant Biotechnologies Ltd.
When is the next analyst rating going to be posted or updated for CollPlant Biotechnologies (CLGN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CollPlant Biotechnologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CollPlant Biotechnologies was filed on February 6, 2026 so you should expect the next rating to be made available sometime around February 6, 2027.
Is the Analyst Rating CollPlant Biotechnologies (CLGN) correct?
While ratings are subjective and will change, the latest CollPlant Biotechnologies (CLGN) rating was a downgraded with a price target of $0.00 to $0.00. The current price CollPlant Biotechnologies (CLGN) is trading at is $0.43, which is out of the analyst’s predicted range.
